Cap commercial prices at a multiple of Medicare
Commercial insurers may not pay more than e.g. 200% of Medicare rates.
Caps commercial prices while private plans remain during the waves.
To review: Set the cap level; too low risks closures.
Review ledgerHow this path connects
This path
Cap commercial prices at a multiple of Medicare
Concrete changes if chosen
What would actually have to change in law, agencies, payment rules, or systems.
- Cap commercial payments at a set multiple of Medicare
- Phase the cap in over several years
Effects
Each effect has its own page: the evidence, the case that it is or isn't a real cost, and whom it affects.
What it fixes
- U.S. prices are far higher than in other countries
Limiting commercial payments relative to Medicare rates offers substantial savings for employers and workers and is simple to enforce. The cap can become a price floor for cheaper hospitals.
What it creates or worsens
- Reduces income or business for affected groups
Hospitals reliant on high commercial payments lose revenue under the cap.
- Price limits can cause shortages, launch delays, or exits
Capping commercial payments reduces revenue for hospitals dependent on high commercial prices.
3 paths soften this
Price floors and supply guarantees for essential productsPrice limits can cause shortages, launch delays, or exitsChosenMonitor supply and adjust prices quicklyPrice limits can cause shortages, launch delays, or exitsChosenRequire timely U.S. launch as a condition of market accessPrice limits can cause shortages, launch delays, or exitsRejected
Who's affected
Who gains
- People with employer coverage
- U.S. prices are far higher than in other countries: Private plans pay the highest prices, passed on through premiums.
- Taxpayers and public budgets
- U.S. prices are far higher than in other countries: Public programs pay more than peer countries too.
- Price limits can cause shortages, launch delays, or exits: Low price limits reduce spending in the short term.
- Employers
- U.S. prices are far higher than in other countries: Limiting commercial payments relative to Medicare rates offers substantial savings for employers and workers and is simple to enforce. The cap can become a price floor for cheaper hospitals.
Who loses
- Hospitals and specialist groups with high private prices
- U.S. prices are far higher than in other countries: Providers with pricing power earn more per service.
- Drug and device makers
- U.S. prices are far higher than in other countries: U.S. prices are well above those in peer countries.
- People with ongoing or specialist care needs
- Price limits can cause shortages, launch delays, or exits: Low price limits may reduce access to products and services through shortages or exits.
Other ways to soften the losses
- Phase in; transition funds for hospitals with low margins
Where it has been tried
- Montana, Oregon (state employee plans): Reference pricing to Medicare saved millions.Sources: RAND Corporation (2024)
Works well with
Other paths for “U.S. prices are far higher than in other countries”
All-payer rate settingU.S. prices are far higher than in other countriesChosenRestore competition and leave prices to marketsU.S. prices are far higher than in other countriesRejectedGlobal budgets for hospitalsU.S. prices are far higher than in other countriesChosenFee-for-service at public fee scheduleU.S. prices are far higher than in other countriesChosenCapitation for primary care and integrated systemsU.S. prices are far higher than in other countriesChosen